Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer
Citations Over Time
Abstract
Various receptor tyrosine kinase (RTK) pathways were verified in many cancers including gastric cancer (GC), We sought to investigate the expression of RTKs including Her2, Her3, and Met and their transduction patterns in human GC. Over-expression of Her2, Her3, and c-Met in human GC was verified by immunohistochemistry leading to constitutive activation of RTK signaling pathways. Combined RTKs expression was valuable indicators for poor prognosis of GC patients. Using ErbB2 specific inhibitor Lapatinib and c-Met specific inhibitor PHA-665752, we further demonstrated that this constitutive activation of RTK signaling is necessary for the survival of GC cells. However, various RTK pattern: Her3/Her2 and Met/Her3 were verified in the transduction growth stimulus from outside via both AKT and MAPK signaling. Moreover, the essential roles of Her3 in both two heterodimers were obtained which showed significantly attenuated growth effect due to Her3 knockdown both in vitro and in vivo. In conclusion, various molecular transduction patterns: Her2/Her3 and Met/Her3 were verified in human GC, and Her3 could serve as a potential target in GC treatment.
Related Papers
- → Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib(2011)131 cited
- → Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71(2005)114 cited
- → Lapatinib in the Treatment of Breast Cancer(2009)2 cited
- Progress on the Relationship between ERK,JNK Signal Transduction Pathway and Diseases(2011)
- → Response and resistance to lapatinib in HER2-overexpressing breast cancer(2014)